Back
Forte Biosciences Vs. Axsome Therapeutics Industry Stock Comparison
Sell
28
FBRX
Forte Biosciences
Last Price:
$7.50
Seasonality Move:
-18.59%
Sell
35
AXSM
Axsome Therapeutics
Last Price:
$111.64
Seasonality Move:
19.74%
Sell
28
Forte Biosciences (FBRX)
is a Sell
Is Forte Biosciences a Buy, Sell or Hold?
-
The current Forte Biosciences [FBRX] share price is $7.43. The Score for FBRX is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
-
FBRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Axsome Therapeutics (AXSM)
is a Sell
Is Axsome Therapeutics a Buy, Sell or Hold?
-
The current Axsome Therapeutics [AXSM] share price is $111.67. The Score for AXSM is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
AXSM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FBRX Stock Price Chart
What is Forte Biosciences's stock price today?
-
The Forte Biosciences share price today is $7.43Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FBRX is experiencing selling pressure, which indicates risk of future bearish movement.
AXSM Stock Price Chart
What is Axsome Therapeutics's stock price today?
-
The Axsome Therapeutics share price today is $111.67Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AXSM is experiencing slight buying pressure.
FBRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.67 | Sell |
Relative Strength Index (14 RSI): | 45.29 | Sell |
Chaikin Money Flow: | -8993 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.13 - 8.55) | Buy |
Bollinger Bands (100): | (6.98 - 20.04) | Sell |
AXSM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.72 | Sell |
Relative Strength Index (14 RSI): | 36.05 | Sell |
Chaikin Money Flow: | 647254 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (119.19 - 127.47) | Sell |
Bollinger Bands (100): | (89.52 - 121.2) | Buy |
FBRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.81 | Sell |
20-day SMA: | 6.95 | Buy |
50-day SMA: | 10.44 | Sell |
200-day SMA: | 11.45 | Sell |
8-day EMA: | 7.63 | Sell |
20-day EMA: | 7.82 | Sell |
50-day EMA: | 9.96 | Sell |
200-day EMA: | 12.53 | Sell |
AXSM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 120.51 | Sell |
20-day SMA: | 122.32 | Sell |
50-day SMA: | 118.5 | Sell |
200-day SMA: | 95.68 | Buy |
8-day EMA: | 118.83 | Sell |
20-day EMA: | 121.23 | Sell |
50-day EMA: | 116.96 | Sell |
200-day EMA: | 99.27 | Buy |
Forte Biosciences Earnings Growth & FBRX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $6.59 per share, a decrease next quarter of $0.00 per share, an increase this year of $8.24 per share, and an increase next year of $1.25 per share.
Axsome Therapeutics Earnings Growth & AXSM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.67 per share, an increase next quarter of $0.33 per share, an increase this year of $1.82 per share, and an increase next year of $4.87 per share.
Forte Biosciences Technical Analysis
Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Axsome Therapeutics Technical Analysis
Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |